Table 2.

Multivariate analysis of having received serum creatinine and fasting plasma glucose testing among patients on ART and in care in 2016

		Serum creatinine monitoring				Fasting plasma glucose monitoring
	N	Proportion monitored (%)	OR	95%CI	p-value	Proportion monitored (%)	OR	95%CI	p-value
Sex
Female	5951	55.5	1.00	-		27.7	1.00	-
Male	12572	63.3	0.82	0.76–0.89	<0.001	37.7	0.82	0.75–0.89	<0.001
Age group (years)					0.560				0.371
≤40	12576	59.1	1.00	-		31.9	1.00	-
41–50	3958	59.7	0.96	0.89–1.04	0.355	34.1	1.04	0.96–1.13	0.330
>50	1989	66.4	0.96	0.87–1.05	0.380	40.7	1.07	0.97–1.17	0.181
HIV exposure category					<0.001				<0.001
Heterosexual	10804	46.0	1.00	-		22.1	1.00	-
MSM	2706	78.8	1.10	0.95–1.26	0.189	59.5	1.66	1.47–1.87	<0.001
IDU	720	82.5	6.15	5.01–7.54	<0.001	48.8	4.05	3.41–4.81	<0.001
Other/unknowna	4293	83.2	-				47.6	-
Pre-ART CD4 count (cells/µL)					0.022				0.060
≥350	8209	63.7	1.00	-		33.3	1.00	-
200–349	4026	55.9	0.86	0.76–0.98	0.018	29.0	0.89	0.79–1.01	0.076
<200	2105	56.1	0.96	0.86–1.07	0.455	29.2	0.99	0.88–1.11	0.891
Missing/not testeda	4183	73.3	-			50.8	-
Viral load					0.005				<0.001
VLS	8890	68.4	1.00	-		45.6	1.00	-
VF	1138	67.1	0.90	0.78–1.04	0.167	37.7	0.67	0.58–0.77	<0.001
Missing/not tested	8495	52.1	0.88	0.81–0.95	0.001	22.5	0.55	0.51–0.60	<0.001
Country income category
Lower-middle	13870	53.5	1.00	-		26.2	1.00	-
High	4653	82.6	7.13	6.27–8.09	<0.001	59.3	5.06	4.52–5.67	<0.001

Notes: Age is age in year of serum creatinine or fasting plasma glucose test;

^aP-values for test for heterogeneity excluded other/unknown or missing/not-tested values.

OR=odds ratio; 95%CI=95% confidence interval; MSM=men who have sex with men; IDU=injecting drug use; VF=virologic failure (≥ 1000 copies/mL); VLS=viral load suppression (<1000 copies/mL).